BSE Live
Sep 05, 16:01Prev. Close
1369.90
Open Price
1371.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Sep 05, 15:58Prev. Close
1370.70
Open Price
1369.10
Bid Price (Qty.)
1372.70 (26)
Offer Price (Qty.)
0.00 (0)
Balance Sheet of Emcure Pharmaceuticals (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
EQUITIES AND LIABILITIES | ||||||
SHAREHOLDER'S FUNDS | ||||||
Equity Share Capital | 189.48 | 181.15 | 180.85 | 180.85 | 180.85 | |
Total Share Capital | 189.48 | 181.15 | 180.85 | 180.85 | 180.85 | |
Reserves and Surplus | 2,834.88 | 1,753.95 | 1,661.02 | 1,531.68 | 2,120.92 | |
Total Reserves and Surplus | 2,834.88 | 1,753.95 | 1,661.02 | 1,531.68 | 2,120.92 | |
Total Shareholders Funds | 3,024.36 | 1,935.10 | 1,841.87 | 1,712.53 | 2,301.77 | |
NON-CURRENT LIABILITIES | ||||||
Long Term Borrowings | 406.29 | 438.21 | 600.65 | 512.40 | 645.97 | |
Deferred Tax Liabilities [Net] | 26.41 | 28.94 | 30.24 | 29.70 | 28.01 | |
Other Long Term Liabilities | 213.78 | 201.11 | 125.48 | 113.26 | 64.97 | |
Long Term Provisions | 26.11 | 23.46 | 21.28 | 21.24 | 33.29 | |
Total Non-Current Liabilities | 672.59 | 691.72 | 777.65 | 676.59 | 772.24 | |
CURRENT LIABILITIES | ||||||
Short Term Borrowings | 249.53 | 976.29 | 1,067.11 | 1,061.39 | 659.59 | |
Trade Payables | 1,120.39 | 821.27 | 673.44 | 601.37 | 574.29 | |
Other Current Liabilities | 321.11 | 308.00 | 236.73 | 248.05 | 511.39 | |
Short Term Provisions | 28.14 | 24.56 | 19.06 | 23.26 | 43.91 | |
Total Current Liabilities | 1,719.16 | 2,130.12 | 1,996.33 | 1,934.06 | 1,789.18 | |
Total Capital And Liabilities | 5,416.11 | 4,756.93 | 4,615.85 | 4,323.18 | 4,863.20 | |
ASSETS | ||||||
NON-CURRENT ASSETS | ||||||
Tangible Assets | 1,732.84 | 1,690.86 | 1,394.02 | 1,255.81 | 1,216.65 | |
Intangible Assets | 26.22 | 27.38 | 38.69 | 51.55 | 61.25 | |
Capital Work-In-Progress | 92.83 | 106.40 | 253.10 | 239.25 | 192.09 | |
Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Fixed Assets | 1,858.17 | 1,824.64 | 1,685.80 | 1,546.61 | 1,469.99 | |
Non-Current Investments | 677.65 | 684.00 | 690.02 | 563.36 | 863.73 | |
Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Long Term Loans And Advances | 320.58 | 41.88 | 46.89 | 24.53 | 278.05 | |
Other Non-Current Assets | 99.65 | 82.97 | 53.64 | 52.64 | 35.96 | |
Total Non-Current Assets | 2,956.06 | 2,633.50 | 2,476.34 | 2,187.13 | 2,647.74 | |
CURRENT ASSETS | ||||||
Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Inventories | 1,038.18 | 770.27 | 709.93 | 730.44 | 621.77 | |
Trade Receivables | 1,190.56 | 1,103.29 | 1,054.50 | 1,009.09 | 999.43 | |
Cash And Cash Equivalents | 13.80 | 32.12 | 141.02 | 47.52 | 260.73 | |
Short Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
OtherCurrentAssets | 217.51 | 217.75 | 234.06 | 348.99 | 333.54 | |
Total Current Assets | 2,460.05 | 2,123.43 | 2,139.51 | 2,136.05 | 2,215.46 | |
Total Assets | 5,416.11 | 4,756.93 | 4,615.85 | 4,323.18 | 4,863.20 | |
OTHER ADDITIONAL INFORMATION | ||||||
CONTINGENT LIABILITIES, COMMITMENTS | ||||||
Contingent Liabilities | 303.72 | 244.08 | 66.56 | 89.11 | 45.52 | |
CIF VALUE OF IMPORTS | ||||||
Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
EXPENDITURE IN FOREIGN EXCHANGE | ||||||
Expenditure In Foreign Currency | 124.47 | 0.00 | 178.84 | 1,166.29 | 126.31 | |
REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
EARNINGS IN FOREIGN EXCHANGE | ||||||
FOB Value Of Goods | 1,611.50 | -- | 1,168.00 | 1,414.14 | 1,537.12 | |
Other Earnings | -- | -- | -- | -- | -- | |
BONUS DETAILS | ||||||
Bonus Equity Share Capital | -- | -- | -- | -- | -- | |
NON-CURRENT INVESTMENTS | ||||||
Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
Non-Current Investments Unquoted Book Value | 677.65 | 684.00 | 690.02 | 563.36 | 863.73 | |
CURRENT INVESTMENTS | ||||||
Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
07.08.2025
Emcure Pharmace Standalone June 2025 Net Sales at Rs 1,096.57 crore, up 13.01% Y-o-Y
17.07.2025
10.07.2025
07.07.2025
07.08.2025
Emcure Pharmace Standalone June 2025 Net Sales at Rs 1,096.57 crore, up 13.01% Y-o-Y
27.05.2025
Emcure Pharmace Consolidated March 2025 Net Sales at Rs 2,116.25 crore, up 19.47% Y-o-Y
23.05.2025
Emcure Pharmace Standalone March 2025 Net Sales at Rs 1,278.19 crore, up 41.62% Y-o-Y
12.02.2025
Emcure Pharmace Standalone December 2024 Net Sales at Rs 1,028.81 crore, up 18.23% Y-o-Y